← Sabra Health Care REIT, Inc. SBRA
Market Price
$20.32
Market Cap
$5.08B
P/E Ratio
31.75
Revenue (FY 2025)
↑25.4% YoY
$356.88M
3-Yr CAGR: 24.1%
Net Income
↑22.8% YoY
$155.61M
Net Margin: 43.6%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
↑18.5% YoY
$0.64
Basic: $0.64
Return on Equity
Efficiency
5.5%
ROA: 2.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SBRA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $260.5M | — | $195.7M | $70.3M | — | $0.92 | — | $176.7M | — | — |
| FY 2017 | $405.6M | +55.7% | $317.2M | $158.4M | +125.4% | $1.40 | +52.2% | $133.5M | — | — |
| FY 2018 | $623.4M | +53.7% | $476.3M | $279.1M | +76.2% | $1.51 | +7.9% | $358.5M | — | — |
| FY 2019 | $128.1M | -79.5% | $1.4M | $69.0M | -75.3% | $0.37 | -75.5% | $372.5M | — | — |
| FY 2020 | $156.0M | +21.9% | $55.6M | $138.4M | +100.6% | $0.67 | +81.1% | $354.9M | — | — |
| FY 2021 | $155.5M | -0.3% | $56.9M | $-113.3M | -181.8% | $-0.52 | -177.6% | $356.4M | — | — |
| FY 2022 | $186.7M | +20.0% | $81.2M | $-77.6M | +31.5% | $-0.34 | +34.6% | $315.7M | — | — |
| FY 2023 | $236.2M | +26.5% | $123.2M | $13.8M | +117.7% | $0.06 | +117.6% | $300.6M | — | — |
| FY 2024 | $284.6M | +20.5% | $169.3M | $126.7M | +821.1% | $0.54 | +800.0% | $310.5M | — | — |
| FY 2025 | $356.9M | +25.4% | $244.4M | $155.6M | +22.8% | $0.64 | +18.5% | $348.6M | — | — |
Valuation
Market Price
$20.32
Market Cap
$5.08B
Enterprise Value
$7.54B
P/E Ratio
31.75
P/B Ratio
1.82
FCF Yield
N/A
Dividend Yield
5.91%
Shares Outstanding
Profitability & Margins
Gross Margin
68.48%
Operating Margin
2.62%
Net Margin
43.60%
Return on Equity (ROE)
5.51%
Return on Assets (ROA)
2.83%
Asset Turnover
0.06x
Revenue 3-Yr CAGR
24.11%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
0.896
Debt / Assets
0.460
Cash & Equivalents
$71.54M
Total Debt
$2.53B
Book Value / Share
$11.19
Cash Flow Efficiency
Operating Cash Flow
$348.61M
Capital Expenditures (CapEx)
N/A
Free Cash Flow
N/A
OCF / Revenue
97.68%
FCF / Revenue
N/A
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.64
EPS (Basic)
$0.64
Dividends / Share
$1.20
Book Value / Share
$11.19
EPS YoY Growth
18.52%
Balance Sheet (FY 2025)
Total Assets
$5.49B
Total Liabilities
$2.67B
Stockholders' Equity
$2.82B
Current Assets
N/A
Current Liabilities
N/A